NCT04017962 2025-08-11
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
GlaxoSmithKline
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center